Beetroot juice modulates physiological responses and accelerates recovery during the special judo performance: a randomized trial Authors: Iskender Guler, Heidar Sajedi, Burcu Fidel, Erdi Kaya, Selahattin Akpınar, Davar Khodadadi, Ismail Laher, Mohammad Babaei Published: 2026 ABSTRACT AbstractThe ability of nitrate (NO₃⁻)-rich beetroot juice (BJ) to improve exercise depends on training status. However, the mechanisms are understudied. The aim of this study was to investigate the impact of acute BJ supplementation on the Special Judo Fitness Test (SJFT) outcomes in elite and recreational judokas.Forty judo athletes (17 elite and 23 recreational) completed two SJFT sessions after drinking either BJ or a placebo in a randomized, double-blind, placebo-controlled crossover design. Plasma NO₃⁻ and lactate, tissue saturation index (TSI) and SJFT outcomes were measured. Plasma NO₃⁻ increased after BJ intake in both groups (p < 0.001). Elite athletes achieved more total throws (TT) (p < 0.05) and exhibited lower TSI during SJFT, 1-min post-SJFT heart rate (HR₁), and SJFT index (p < 0.05), but higher post-SJFT lactate and TSI than recreational athletes (p < 0.05). TT did not improve following supplementation (p > 0.05). BJ increased post-SJFT TSI (elite: 2.6 ± 3% vs. recreational: 4.55 ± 2.6%) and reduced HR₁ (elite: − 5.6 ± 3.3% vs. recreational: − 9.8 ± 4.7%) and SJFT index (elite: − 2.7 ± 5.6% vs. recreational: − 6 ± 5.8%) overall (p < 0.001 compared to placebo), with greater effects in recreational athletes (p < 0.05). BJ also decreased post-SJFT lactate only in recreational athletes (p < 0.01). Higher maximal oxygen uptake correlated with smaller BJ-induced improvements in lactate (r = − 0.57, p < 0.001), HR₁ (r = − 0.50, p < 0.001), SJFT index (r = − 0.43, p < 0.01), and TSI during the third period of SJFT effort (r = − 0.5, p < 0.001) and during 1-min recovery (r = − 0.35, p < 0.05). BJ primarily attenuates the physiological cost and enhances recovery-related markers during the judo performance, rather than directly increasing the performance, with responsiveness modulated by training status.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-52444-4.Keywords: Nitrate supplementation, Judo performance, Heart rate recovery, Tissue oxygenation, Training statusSubject terms: Health care, Medical research, Physiology Introduction Judo is a combat sport where athletes score points by throwing an opponent to the ground or achieving a hold/submission1. Matches can be very short (a single point or “Ippon” ends the bout) or last over 4 min plus potential overtime1. Thus, judokas must develop both advanced technical-tactical skills and a high level of physical fitness. The physiological demands are high, as repeated explosive and complex movements in the standing and ground phases place athletes under significant stress2. Energy system analysis indicated that judo engages all metabolic pathways: anaerobic systems fuel the rapid throws, locks, and holds (with and without lactate), while aerobic capacity is crucial for sustaining repeated attacks, maintaining alertness, and supporting muscular strength during prolonged efforts3. Choosing the appropriate dietary supplements can help optimize athletes’ performance. Natural foods like vegetables and fruits are rich in bioactive compounds and can serve as alternatives to synthetic supplements for enhancing physiological function4. Beetroot juice (BJ) is particularly high in inorganic nitrate (NO₃⁻) and improves various aspects of exercise performance. For example, BJ supplementation prolongs time to exhaustion in aerobic and muscular endurance activities, enhances performance in high-intensity interval exercise, improves cognitive function, reduces the phosphocreatine (PCr) cost of force production, alleviates perceived muscle soreness after exercise, and accelerates recovery following exercise-induced muscle damage5–11. These performance benefits are attributed to increased nitric oxide (NO) availability after BJ intake12. NO is a signaling molecule that enhances blood flow distribution, mitochondrial respiration, endothelial function, and skeletal muscle metabolism and contraction13–16. Despite its promising effects, research on the acute effects of BJ supplementation in combat sports remains limited with mixed results. For example, de Oliveira et al.17 reported that acute beetroot gel (12.2 ± 0.2 mmol of NO₃⁻) improved handgrip strength recovery without altering muscle oxygenation in recreational combat athletes. Study by Miraftabi et al.18 indicated that acute BJ (400–800 mg of NO₃⁻) increased aerobic and anaerobic capacity in taekwondo athletes but failed to translate this into improved sport-specific performance. Antonieto et al.19, however, demonstrated that a single dose of beetroot extract (1 g) enhanced aerobic capacity and improved sport-specific test results in taekwondo athletes. These inconsistent findings highlight the complexity of BJ’s acute impact and likely reflect a combination of factors, including the specific nature of the tests employed (e.g., non-specific vs. sport-specific), the differing populations studied (recreational vs. elite), and potentially varying baseline fitness levels, encompassing not only aerobic capacity but also anaerobic power, strength-endurance, and overall conditioning status crucial for combat sports performance. Dietary inorganic NO₃⁻ is reduced sequentially to nitrite (NO₂⁻) and NO via enterosalivary and tissue pathways. NO exerts multiple effects that are plausibly relevant for judo: (i) vasodilation and microvascular recruitment; (ii) modulation of mitochondrial respiration and reduced oxygen cost of ATP production; and (iii) potential influences on autonomic regulation (parasympathetic reactivation)14,20. Given the intermittent, high-intensity nature of judo that alternates maximal explosive efforts and short recovery periods, increased NO availability could therefore improve the efficiency of recovery between efforts and possibly lower metabolic cost for a given output. Based on these mechanisms, we hypothesized that acute BJ would (a) increase systemic NO₃⁻, (b) enhance muscle oxygenation recovery and autonomic recovery, (c) improve judo performance efficiency, and (d) reduce metabolic cost, with larger effects in athletes with lower baseline aerobic fitness. To our knowledge, no prior study has directly tested the acute effects of BJ on judo-specific performance or examined how athlete training status influences these effects. In addition, the mechanisms by which acute BJ ingestion causes probable alterations in the special judo performance are not fully understood. Therefore, the aim of this study was to investigate the impact of acute BJ supplementation on the Special Judo Fitness Test (SJFT) outcomes in both elite and recreational judokas. Methods Participants An a priori power analysis (G*Power v. 3.1.9.4) determined that 34 participants were required to detect a difference between conditions, given an estimated effect size of 0.5, a statistical power of 80%, and an alpha error of < 0.05. To account for potential dropouts, we enrolled 40 adult judokas, including 17 elite (national-level; 11 males, 6 females) and 23 recreational (15 males, 8 females) athletes. All participants provided written informed consent after being fully informed about the research procedures, including any risks and benefits. The elite judokas were defined as black belts (1st to 4th Dan) with a minimum of 5 years of experience in judo, averaging ∼24 h of exercise training per week over the preceding 6 months. Crucially, these elite athletes were also active competitors at the national level, possessing at least 3 years of competitive experience at this level, and had achieved a top 3 national ranking within the last year. Conversely, the recreational group comprised individuals holding purple (n = 7) or brown (n = 16) belts, with ≤ 3 years of judo experience and ∼7 h of training per week. These athletes primarily participated in club-level training for fitness and personal development and did not have a history of participating in provincial or national championships prior to the study (see Table 1). All participants were healthy, free from neuromuscular or musculoskeletal disorders, non-smokers, non-alcohol drinkers, and not taking any medications regularly. The study was conducted during the 4-week transition (off-season) phase. During this period, elite athletes continued training 5 times per week (3 judo-specific and 2 general conditioning sessions, including strength training), while recreational athletes trained 3 times per week (judo-specific sessions). Testing in female athletes occurred during the late follicular menstrual phase. Participants were excluded if they experienced any pain or discomfort, failed to complete all trials, or did not follow study instructions. All 40 participants completed the study without any dropouts or adverse events (Fig. 1: CONSORT flow diagram). Table 1Participant baseline characteristics.Elite (n = 17)Recreational (n = 23)Age (y)24.7 ± 3.722.9 ± 2.9SexMale = 11, Female = 6Male = 15, Female = 8Height (cm)177.3 ± 6.6178.8 ± 8.2Body mass (kg)84 ± 21.381.5 ± 19.2Body fat (%)13.7 ± 3.215.5 ± 3.8V̇O2max (ml/kg/min)58.2 ± 5.9*45.4 ± 3.4Judo experience (year)7.7 ± 2.6*2.2 ± 1.3Training hours/week (h)24.4 ± 6.1*7.2 ± 1.6Data are presented as mean ± standard deviation. The judo athletes spanned multiple weight categories from − 49 to + 100 kg. *P < 0.001 different from recreational athletes. V̇O2max, maximal oxygen consumption. Participant baseline characteristics. Data are presented as mean ± standard deviation. The judo athletes spanned multiple weight categories from − 49 to + 100 kg. *P < 0.001 different from recreational athletes. V̇O2max, maximal oxygen consumption. The CONSORT flow diagram. Experimental design This study used a randomized, double-blind, placebo-controlled crossover design with four sessions for each participant. The familiarization session allowed athletes to practice one set of the SJFT, and they were trained to use the Borg rate of perceived exertion (RPE) scale (6–20). Subsequently, anthropometric and maximal oxygen consumption (V̇O2max) measurements were obtained in the second session, which was carried out three days after the familiarization. Each participant then completed two experimental sessions separated by at least 5 days, allowing for recovery. In each experimental session, participants ingested 140 ml of either BJ (Beet It Sport®, James White Drinks Ltd., UK; ∼12.8 mmol NO₃⁻, energy ∼140 kcal) or placebo (NO₃⁻-depleted BJ, Beet It Sport®, James White Drinks Ltd., UK; < 0.05 mmol NO₃⁻, energy ∼140 kcal), which had exactly the same color and taste and were packaged in bottles with the same appearance. The order of supplement administration was randomized and counterbalanced. The RAND function of Excel software was used for randomization, and a researcher who was not involved in data collection and analysis coordinated the randomization. Both participants and investigators were blinded to the treatment. Participants remained seated after consuming BJ or placebo and relaxed in the gym for 120 min. Volunteers completed the SJFT under the supervision of a qualified coach. To control for dietary sources of nitrites, participants were instructed to avoid NO₃⁻-rich foods (e.g., beets, celery, spinach, lettuce, etc.) for 48 h before each trial. Participants were also instructed to maintain a high-carbohydrate diet for 24 h prior to the experiments. They recorded all foods and beverages consumed during this 24-h period, continuing the diet before the second session. A nutritionist provided individualized consultations and monitored dietary adherence throughout the study. Volunteers also refrained from strenuous exercise for 72 h prior to each test and maintained consistent sleep schedules. All testing sessions were conducted between 07:00 and 10:00 following an overnight fast to minimize circadian and dietary influences, allowing for a more precise evaluation of the direct effects of BJ on performance metrics. Verbal encouragement was standardized and given throughout each SJFT trial. The protocol of this study was in accordance with the Declaration of Helsinki (2013) and was approved by the Ethics Committee for Human Research at International Science and Technology University (202,505–03). Informed consent was obtained from all participants. This study was carried out in Turkey and was registered with the Iranian Registry of Clinical Trials (IRCT20231004059615N3) from 2025-05-22. Anthropometric and V̇O2max measurements We first measured body mass and body fat percentage during the second session using a bioelectrical impedance analyzer (InBody 970; Biospace, South Korea). Participants then performed an incremental cycling test to determine V̇O2max. After a 5-min warm-up at 150 W, the workload increased by 30 W every 3 min until volitional exhaustion. Respiratory data (V̇O₂, V̇CO₂, and ventilation) were collected breath-by-breath using an online metabolic cart (PowerCube-Ergo, Ganshorn, Germany), which was calibrated before each test. The highest 10-s average V̇O₂ was recorded as V̇O2max. We confirmed attainment of V̇O2max when at least three of the following criteria were met: (a) a plateau in V̇O₂ despite increased workload, (b) respiratory exchange ratio (RER) > 1.20, (c) peak Heart rate (HR) ≥ 90% of age-predicted maximum, and/or (d) observable exhaustion21. SJFT protocol A standardized warm-up consisting of 5 min of jogging was performed, which was followed by 5 min of supervised dynamic exercises (such as walking lunges, heel flicks, high knees, big arm circles, leg swings, and jumping jacks)22, and ending with 5 min of the ippon-seoi-nage technique uchikomi (repetition training). Participants then completed the SJFT. The SJFT is a specific evaluation test divided into three periods of effort after 5 min of passive rest: (A = 15 s, B and C = 30 s each), with 10 s of intervals between them. Two ukes (thrown colleagues) were positioned 6 m away, and the tori (participant) ran towards each uke and threw them as many times as possible using the ippon-seoi-nage technique. All athletes involved had similar heights (± 3 cm) and body masses (± 2 kg). HR was measured (Polar RS800CX, Finland) immediately at the end (HR0) and 1 min after the test (HR₁). The SJFT index (Index = HR0 + HR₁ / TT) was calculated from the total number of throws (TT), HR0, and HR₁; a lower index value indicates better performance in the test23,24. Immediately following effort C, the participants indicated their perceived exertion levels on the Borg RPE scale. The session ended with a 5-min cool-down. Muscle oxygenation measurements Muscle oxygenation was recorded continuously during the entire SJFT using a near-infrared spectroscopy system (NIRS). A portable NIRS device (Portamon, Artinis Medical Systems, Netherlands) was placed unilaterally on the vastus lateralis muscle on each subject’s dominant side. The NIRS device uses three light source transmitters (each with two wavelengths between 750 and 850 nm) at 30, 35, and 40 mm distance to the receiver to monitor three separate regions of the tissue simultaneously. A sample rate of 10 Hz was used to record the data. The tissue saturation index (TSI, %) was calculated using the manufacturer’s software, based on variations in the concentrations of oxygenated hemoglobin, deoxygenated hemoglobin, and total hemoglobin. Baseline TSI was assessed from the resting values recorded over the last 30 s of a 5-min resting period preceding the start of the SJFT. The averaged TSI was analyzed separately for each part of the SJFT (effort A, rest 1, effort B, rest 2, effort C, 1-min post-SJFT recovery). To ensure that all participants had skinfold thicknesses less than 15 mm25, a skinfold measurement was taken on the dominant side vastus lateralis muscle using a Harpenden skinfold caliper. Plasma measurements Venous blood was drawn from the antecubital vein with participants seated, immediately before the supplementation at baseline, before the onset of exercise, and 5 min after exercise into tubes containing ethylenediamine tetra-acetic acid (EDTA). Samples were centrifuged at 3,500 rpm for 10 min at 4 °C, after which plasma was aliquoted into microcentrifuge tubes and stored at − 80 °C until analysis. Lactate was measured using a human lactate ELISA kit (ab287808, Abcam). To measure NO₃⁻ and NO₂⁻ levels, plasma was deproteinized 1:1 (v/v) with ice‑cold methanol, centrifuged at 12,000 g for 10 min, and the supernatant diluted with the ENO‑20 system’s running buffer (10 mM phosphate, pH 3.0). NO₃⁻ and NO₂⁻ were separated on a sulfonated polystyrene‑divinylbenzene column maintained at 40 °C and quantified by ion‑exclusion high‑performance liquid chromatography with post‑column Griess derivatization (ENO‑20; EiCom, Kyoto, Japan). In this method, NO2⁻ reacts directly with Griess reagent to form an azo dye, while NO₃⁻ is first reduced to NO2⁻ in a cadmium reduction column before dye formation; both are detected photometrically at 540 nm. Concentrations were calculated against external calibration curves (0.1–100 µM), yielding intra‑ and inter‑assay coefficients of variation < 5%26. Plasma NO₂⁻ concentrations were below the assay quantification limit (1 µM) in all participants; therefore, only plasma NO₃⁻ is reported. Blinding efficacy Participants were asked which supplement they believed they had consumed (“BJ”, “placebo”, or "I do not know") at the conclusion of each experimental session to evaluate the success of blinding27. Statistical analyses Data are presented as mean ± standard deviation (SD). Statistical analyses were performed using SPSS version 27. Normality was tested with the Shapiro–Wilk test and homogeneity of variance with Levene’s test. The blinding efficacy was assessed by Chi-Square (χ2) test. Baseline differences between groups (elite vs. recreational) were assessed by independent t-tests. Plasma parameters and NIRS scores were examined with a three‑way repeated‑measures Analysis of Variance (ANOVA) (time (3) × condition (2) × group (2) for NO₃⁻ and lactate, and time (7) × condition (2) × group (2) for TSI). Performance outcomes (HR0, HR₁, TT, and SJFT index) were examined using a two‑way repeated‑measures ANOVA with condition (2) and group (2) as factors. A two‑way repeated‑measures ANOVA (time (7) × group (2)) was also carried out on the absolute changes (BJ—placebo) of TSI scores. Bonferroni correction was used to post hoc comparisons if the significant F ratio was detected. Pearson’s correlation coefficients were calculated between training status (V̇O2max) and the absolute change in each outcome (BJ—placebo). Effect size for ANOVA was calculated using partial eta squared (ηp2) (< 0.01, 0.01–0.059, 0.06–0.139, and ≥ 0.14 for trivial, small, moderate, and large effects, respectively). For pairwise comparisons, Hedge’s g (g) was calculated to provide a standardized mean difference that accounts for unequal sample sizes, with values of < 0.20, 0.20–0.49, 0.50–0.79, and ≥ 0.80 interpreted as trivial, small, moderate, and large effects, respectively. The 95% confidence intervals (CIs) were also calculated. A p-value < 0.05 was considered statistically significant. Results All participants completed the study and were included in the statistical analysis. Baseline characteristics are shown in Table 1. Elite judokas had a significantly higher V̇O2max (p < 0.001, g = 2.7, 95% CI [55.1, 61.2] vs. [43.9, 46.8]), judo experience (p < 0.001, g = 3.1, 95% CI [6.3, 9] vs. [1.6, 2.2]), and training hours per week over the last 6 months (p < 0.001, g = 4, 95% CI [21.2, 27.6] vs. [6.5, 7.9]) compared with recreational athletes. The blinding assessment showed that there was no significant difference between the correct responses to recognize BJ and placebo supplementation (χ2 (1) = 3.340, p = 0.314). The blinding answers for the 2 experimental sessions were as follows: mean values (%) for BJ: elite, true = 20%, false = 30%, unable = 50%, and recreational, true = 33.3%, false = 25%, unable = 41.6%; for placebo: elite, true = 30%, false = 30%, unable = 40%, and recreational, true = 25%, false = 41.6%, unable = 33.3%. The analysis of NO₃⁻ revealed significant main effects of time (F = 316.509, p < 0.001, ηp2 = 0.89) and condition (F = 346.085, p < 0.001, ηp2 = 0.9), as well as a time × condition interaction (F = 328.672, p < 0.001, ηp2 = 0.89). BJ increased NO₃⁻ concentration in both elite and recreational judokas at pre- (95% CI for elite [491, 670] and recreational [505, 669] judokas) and post-SJFT (95% CI for elite [497, 683] and recreational [619, 690] judokas) compared to baseline (95% CI for elite [32.2, 44.1] and recreational [32, 41.7] judokas) and placebo (95% CI for elite [34.4, 47] and recreational [31.4, 43.1] judokas at pre-SJFT and 95% CI for elite [32.4, 45.3] and recreational [32.7, 44.5] judokas at post-SJFT) (p < 0.001, large effects; Fig. 2). Plasma nitrate (NO₃⁻) concentration after a single dose ingestion of beetroot juice (BJ) and Special Judo Fitness Test (SJFT). *P < 0.001 different from baseline (pre-supplement); #P < 0.001 different from placebo condition. Three‑way repeated‑measures ANOVA indicated significant main effects of time (F = 158.978, p < 0.001, ηp2 = 0.98) and group (F = 9.074, p < 0.01, ηp2 = 0.19), as well as time × group (F = 5.731, p < 0.01, ηp2 = 0.13) and time × condition (F = 16.651, p < 0.001, ηp2 = 0.3) interactions for lactate. Compared to baseline, lactate concentration increased post-SJFT in both elite (placebo: p < 0.001, g = 5.5, 95% CI [1.1, 1.4] vs. [15.4, 17.1]; BJ: p < 0.001, g = 6.7, 95% CI [1.2, 1.6] vs. [15.3, 16.8]) and recreational (placebo: p < 0.001, g = 4.2, 95% CI [1.1, 1.4] vs. [14.2, 15.7]; BJ: p < 0.001, g = 4, 95% CI [1, 1.4] vs. [13.8, 15.3]) athletes. Elite athletes had a greater increase in lactate concentration than recreational judokas, regardless of supplementation (placebo: p < 0.05, g = 0.72; BJ: p < 0.01, g = 0.95). BJ decreased post-SJFT plasma lactate in recreational athletes (p < 0.001, g = 1.2) but not in elite athletes (p = 0.1, g = 0.41; Fig. 3). Plasma lactate concentration after Special Judo Fitness Test (SJFT) following beetroot juice (BJ) or placebo. *P < 0.001 different from baseline (pre-supplement); #P < 0.01 different from placebo condition; $P < 0.05 different from recreational athletes. Three‑way repeated‑measures ANOVA on TSI values showed significant main effects of condition (F = 22.322, p < 0.001, ηp2 = 0.37) and time (F = 107.313, p < 0.001, ηp2 = 0.74), as well as interaction effects of time × group (F = 9.058, p < 0.001, ηp2 = 0.19), condition × time (F = 7.531, p < 0.001, ηp2 = 0.16), and condition × time × group (F = 2.674, p < 0.05, ηp2 = 0.07). There was not a significant main effect for group (F = 1.249, p = 0.271, ηp2 = 0.03) or condition × group (F = 3.939, p = 0.054, ηp2 = 0.09) interaction. The significant main effects of time (F = 7.531, p < 0.001, ηp2 = 0.16) and time × group interaction (F = 2.674, p < 0.05, ηp2 = 0.07) were also observed by the two‑way repeated‑measures ANOVA on the absolute change of TSI scores. However, the main effect of group was not statistically significant (F = 3.939, p = 0.054, ηp2 = 0.09). Regardless of supplementation, TSI decreased during different periods of the SJFT compared to baseline values (p < 0.01, moderate to large effects), with greater reduction observed in elite athletes (p < 0.05, moderate to large effects). The tissue oxygen re-saturation during the 1-min recovery period was also faster in elite athletes than in recreational athletes during both placebo (p < 0.01, g = 0.89, 95% CI [8.3, 13.4] vs. [3.4, 8.5]) and BJ conditions (p < 0.001, g = 1.4, 95% CI [11.2, 15.2] vs. [5.8, 9.3]). During the second (p < 0.001, g = 0.74, 95% CI [58.1, 63.7] vs. [55, 61.9]) and third (p < 0.001, g = 0.95, 95% CI [55.5, 60.9] vs. [51.5, 58.7]) periods of effort (efforts B and C), as well as during the second 10-s rest period (p < 0.01, g = 0.74, 95% CI [59.2, 64.5] vs. [56.9, 63.3]) in SJFT, the TSI scores of recreational, but not elite athletes, were increased in the BJ condition compared to the placebo condition. Compared to the placebo condition, BJ increased TSI during the 1-min recovery after the test in both elite (p < 0.01, g = 0.85, 95% CI [60.2, 67.7] vs. [63.2, 69.9]) and recreational athletes (p < 0.001, g = 1.7, 95% CI [57.9, 63.8] vs. [62.8, 68.2]), with a significantly greater effect in the recreational group (p < 0.05, g = 0.7; Fig. 4). Tissue saturation index (TSI) during Special Judo Fitness Test (SJFT) after beetroot juice (BJ) or placebo intake in elite (A) and recreational athletes (B). The absolute changes (BJ—placebo) of TSI scores during the SJFT (C). *P < 0.01 different from baseline; #P < 0.05 different between BJ and placebo condition; $ P < 0.05 different between elite and recreational athletes. No significant main effects were detected for group (F = 0.775, p = 0.384, ηp2 = 0.02) or condition (F = 0.594, p = 0.446, ηp2 = 0.01), as well as the group × condition interaction effect (F = 0.163, p = 0.689, ηp2 = 0.00) for HR0. In contrast, HR₁ exhibited significant main effects of group (F = 48.588, p < 0.001, ηp2 = 0.71) and condition (F = 123.029, p < 0.001, ηp2 = 0.76), as well as a significant group × condition interaction (F = 13.812, p < 0.001, ηp2 = 0.27). Specifically, recreational judokas had higher HR₁ than elites under both placebo (p < 0.001, g = 3.4, 95% CI [156, 162] vs. [134, 140]) and BJ (p < 0.001, g = 2.6, 95% CI [141, 146] vs. [127, 131]) conditions, and BJ ingestion significantly reduced HR₁ compared to placebo (elite: p < 0.001, g = 1.6; recreation: p < 0.001, g = 2). The group × condition interaction indicates that recreational athletes experienced a larger decrease in HR₁ with BJ than elite athletes (Table 2). Table 2SJFT outcomes following BJ and placebo consumption in elite and recreational judo athletes.BJPlaceboEliteRecreationalEliteRecreationalTT (n)29.2 ± 2.1*25.2 ± 1.329 ± 1.6*24.9 ± 1.9HR0 (beats/min)180.8 ± 6.3182.4 ± 6.6181 ± 6.4183 ± 6.8HR₁ (beats/min)129.3 ± 3.6*#143.3 ± 6.2#$137.2 ± 5.5*159.1 ± 6.6SJFT index10.7 ± 0.8*#12.9 ± 0.9#$11 ± 0.7*13.8 ± 1.2RPE13.2 ± 1.613.3 ± 1.513.4 ± 1.413.9 ± 1.4Data are presented as mean ± standard deviation. SJFT, Special Judo Fitness Test; TT, total number of throws; HR0, heart rate immediately at the end of SJFT; HR₁, heart rate 1 min after SJFT; RPE, rate of perceived exertion. *P < 0.05 different from recreational athletes; #P < 0.05 different from placebo condition. $P < 0.05 larger change with BJ than elite athletes. SJFT outcomes following BJ and placebo consumption in elite and recreational judo athletes. Data are presented as mean ± standard deviation. SJFT, Special Judo Fitness Test; TT, total number of throws; HR0, heart rate immediately at the end of SJFT; HR₁, heart rate 1 min after SJFT; RPE, rate of perceived exertion. *P < 0.05 different from recreational athletes; #P < 0.05 different from placebo condition. $P < 0.05 larger change with BJ than elite athletes. For TT, only the group effect was significant (F = 64.480, p < 0.001, ηp2 = 0.63): elite athletes performed more throws than recreational judokas (placebo: 95% CI [28.2, 29.9] vs. [24.1, 25.7]; BJ: 95% CI [28.1, 30.3] vs. [24.7, 25.8]). There was no significant main effect of condition (F = 0.947, p = 0.337, ηp2 = 0.02), and no interaction (F = 0.232, p = 0.633, ηp2 = 0.01) on TT (Table 2). The SJFT index showed significant main effects of group (F = 37.391, p < 0.001, ηp2 = 0.65) and condition (F = 23.927, p < 0.001, ηp2 = 0.39) as well as their interaction (F = 5.591, p < 0.05, ηp2 = 0.13). Elite athletes had a lower SJFT index than recreational judokas under both placebo (p < 0.001, g = 2.7, 95% CI [10.6, 11.4] vs. [13.3, 14.3]) and BJ (p < 0.001, g = 2.6, 95% CI [10.3, 11.1] vs. [12.6, 13.3]) conditions, and BJ ingestion led to a lower index (better performance) compared to placebo (elite: p < 0.05, g = 0.68; recreation: p < 0.001, g = 1). Additionally, the group × condition interaction suggests that recreational athletes experienced a larger decrease in the SJFT index following BJ supplementation than elite athletes (Table 2). There were no significant main effects of group (F = 0.578, p = 0.482, ηp2 = 0.01) or condition (F = 2.782, p = 0.104, ηp2 = 0.07), nor interaction effects (F = 0.917, p = 0.344, ηp2 = 0.02) for RPE (Table 2). The absolute changes (BJ—placebo) for study outcomes in elite and recreational athletes are presented in Table S1. We observed a significant moderate correlation coefficient between V̇O2max and the absolute change in lactate (r = − 0.57, p < 0.001), HR₁ (r = − 0.50, p < 0.001), SJFT index (r = − 0.43, p < 0.01), and TSI during the third period of SJFT effort (r = − 0.5, p < 0.001) and during 1-min recovery (r = − 0.34, p < 0.05). There was no significant correlation between V̇O2max and the absolute change in HR₀ (r = − 0.06, p > 0.05), TT (r = 0.19, p > 0.05), RPE (r = − 0.27, p > 0.05), or TSI during the baseline (r = 0.06, p > 0.05), first period of effort (r = 0.16, p > 0.05), first period of rest (r = − 0.04, p > 0.05), second period of effort (r = − 0.12, p > 0.05), and second period of rest (r = − 0.3, p > 0.05) in the SJFT (Fig. 5). Correlation coefficients between training status expressed by V̇O2max and the absolute change in Special Judo Fitness Test (SJFT), heart rate immediately at the end of SJFT (HR0), heart rate 1 min after SJFT (HR₁), total number of throws (TT), rate of perceived exertion (RPE), and tissue saturation index (TSI) during different periods of the SJFT. Discussion The primary aim of this study was to assess the acute effects of BJ on judo-specific performance outcomes, and the secondary aim was to determine how training status modulates BJ’s ergogenic effects. Our findings indicate that elite judokas generally performed better on the SJFT, executing more throws and having lower HR₁ and SJFT index values compared to recreational judokas; however, they exhibited lower TSI during the SJFT and higher post-SJFT TSI and lactate levels than recreational athletes, regardless of supplement intake. Acute BJ ingestion resulted in almost similar increases in plasma NO₃⁻ of both elite and recreational athletes (elite: 1587 ± 654% vs. recreational: 1787 ± 1133%, p = 0.487, effect size = 0.21). BJ accelerated tissue O2 re-saturation, attenuated HR₁, and reduced the SJFT index across both groups, indicating faster post-exercise recovery. Importantly, although the SJFT index improved after BJ—largely driven by reductions in HR₁—the primary task outcome, TT, did not increase significantly in either group. Therefore, the principal finding is that acute BJ improved physiological recovery efficiency rather than significantly increasing the performance within the fixed SJFT time. This distinction is critical because a lower SJFT index with unchanged TT indicates faster recovery and lower physiological cost for the same performance output. In addition, recreational athletes experienced a greater reduction in HR₁ (elite: − 5.6 ± 3.3% vs. recreational: − 9.8 ± 4.7%, p < 0.01) and SJFT index (elite: − 2.7 ± 5.6% vs. recreational: − 6 ± 5.8%, p < 0.05) as well as a greater increase in post-SJFT TSI (elite: 2.6 ± 3% vs. recreational: 4.55 ± 2.6%, p < 0.05) with BJ than elites. BJ also decreased post-SJFT lactate only in the recreational athletes (− 2.86 ± 2.5% in recreational vs. − 0.93 ± 2.4% in elite judokas, p < 0.05). The inverse correlations between V̇O2max and BJ-induced improvements in lactate, HR₁, SJFT index, and TSI during 1-min recovery indicate that less-fit athletes gained more benefit from BJ. These findings suggest that the recovery ergogenic effects of acute BJ are influenced by training status, with more pronounced effects observed in athletes with lower fitness levels. Our study indicates that elite judokas achieved a higher average TT compared to recreational judokas. However, the modest increases in TT following BJ consumption (0.45 ± 5.5% for elite athletes and 1.7 ± 5.8% for recreational athletes) did not reach statistical significance (p > 0.05). Given that the SJFT employs a fixed duration for each segment (A: 15 s; B: 30 s; C: 30 s) and the average time per throw for our athletes was approximately 2.4 s (elite) to 2.8 s (recreational), the window for acutely increasing the TT within the constrained timeframe is inherently limited. The primary physiological adaptations influenced by BJ, such as improved oxygen utilization and reduced ATP cost of muscle contraction, are more likely to manifest as an enhanced capacity for sustained high-intensity efforts and accelerated recovery kinetics, rather than a direct, acute increase in the rate or force production of individual, near-maximal actions performed in rapid succession. Therefore, while BJ may have conferred subtle benefits to throw efficiency or fatigue resistance, these benefits were insufficient to translate into a statistically significant increase in the TT within the brief, fixed work periods of the SJFT. This finding is consistent with literature in other combat sports where similar fixed-duration, high-intensity tests did not show changes in primary output after BJ supplementation, despite improvements in underlying aerobic capacity or fatigue markers18. Moreover, it is more likely that our study was underpowered to detect statistically significant changes in TT and a larger sample size may be need to detect such smaller performance changes. Our findings of no effects of BJ on HR0 or RPE are consistent with previous studies indicating that BJ supplementation does not affect RPE18,28,29 or maximal HR18,30 immediately at the end of the exercise. HR₁ is a simple marker of parasympathetic reactivation after exercise. Faster HR recovery is advantageous in sports like judo, where athletes may need to perform multiple high-intensity efforts during the competition day or when judokas undergo multiple training sessions in a day31. In our study, BJ accelerated HR recovery (lower HR₁) in both groups, with a larger effect in recreational athletes. This faster recovery likely underlies the improved SJFT index. The greater impact on recreational judokas and the negative correlation with V̇O2max suggest that those with lower fitness had more capacity for improvement. The mechanism may involve increased NO availability, enhancing parasympathetic (vagal) activation post-exercise32. Additionally, the lower lactate in recreational athletes after acute BJ supplementation suggests reduced physiological cost of equivalent performance. This likely results from BJ-enhanced muscle perfusion and mitochondrial efficiency, which decrease reliance on anaerobic glycolysis and aid post-test recovery. The SJFT index (which combines HR and throws) improved in both groups after BJ, primarily due to lower HR₁. Since throws did not change significantly, the index gains reflect better recovery. The larger index improvement in recreational judokas (and its inverse relationship with V̇O2max) further supports that lower-fit athletes responded more to BJ. This suggests that an acute dose of BJ can improve physiological recovery in judo-specific performance, especially in recreational athletes. TSI quantifies the average O2 saturation of the tissue based on the dynamic balance between O2 supply and demand25. Our NIRS data reveal clear effects on muscle oxygenation during and after the SJFT. TSI declined during each bout of intense throwing, reflecting high O₂ extraction. This desaturation was greater in elite judokas (a larger drop from baseline) than in recreational judokas, indicating that they achieved higher muscle O₂ utilization per effort. In other words, elite muscles extracted more O₂ (lower TSI) under load, consistent with their superior anaerobic/aerobic capacity. During the 1-min post-SJFT recovery, TSI returned (re-saturated) toward baseline. Elite athletes showed faster re-saturation than recreational athletes, reflecting their better capillarization and blood flow recovery. Interestingly, acute BJ ingestion accelerated the post-SJFT re-saturation of muscle TSI in both groups. This likely suggests that NO₃⁻-enhanced NO availability increased blood perfusion to recovering muscles, elevating O₂ supply. In support of this observation, Tan et al. (2022) found that BJ sped reoxygenation (increased TSI) during recovery after resistance exercise33. Moreover, dietary NO₃⁻ has been shown to improve muscle perfusion and oxygenation (e.g., increased microvascular O₂ delivery after exercise)20. In this study, BJ increased muscle oxygenation during efforts B-to-C only in recreational judokas. In addition, recreational athletes experienced a larger BJ-induced increase in post-SJFT TSI than elites. This disparity again aligns with training status; less-fit muscles are more responsive to augmented NO-mediated blood flow, whereas elite muscles already have efficient perfusion. Therefore, BJ more effectively increased muscle oxygenation during judo efforts as well as during recovery, especially in recreational judokas, which likely facilitates oxygen utilization during exercise and faster clearance of metabolites, thereby promoting performance recovery. It is important to note that BJ’s ergogenic effects may depend on multiple factors, such as the type of exercise, supplementation protocol (acute vs. chronic), dose and timing of intake, control of dietary NO₃⁻, and individual characteristics (e.g., sex, fitness level)18,34,35. This study provides the first direct comparison of how physical fitness influences acute BJ effects in judo. Our results are consistent with evidence that well-trained athletes often experience minimal benefits from BJ29,36–38, whereas recreational athletes can gain more benefits17,39. For example, Fernández-Elías et al.36 reported no match performance improvement in professional tennis players after BJ, whereas Wylie et al.39 found that recreational team-sport players improved their Yo-Yo test by ∼4% following BJ supplementation. According to the study by Peacock et al.40, ingestion of NO₃⁻ 2.5 h before exercise neither reduced submaximal oxygen consumption during a low-intensity exercise nor enhanced 5-km running performance compared with placebo in well-trained cross-country skiers. Another study by Porcelli et al.41 demonstrated that less-fit runners improved their 3-km running time with chronic NO₃⁻ supplementation, while highly trained runners did not. The greater BJ-induced changes in recreational athletes may reflect a larger scope for improvement compared with elite athletes (i.e., a ceiling effect). The concept of a ceiling effect in this context refers not solely to maximal aerobic capacity, but rather to the relative developmental stage of the NO pathway and associated microvascular and mitochondrial efficiencies within a judo-specific elite athlete population. Elite judokas, through years of high-intensity intermittent training, are expected to have already optimized many aspects of their NO bioavailability and downstream physiological processes (e.g., capillary density, mitochondrial function) to a greater extent than recreational counterparts. While their absolute V̇O2max might not reach that of an elite endurance athlete, their specific physiological adaptations for their sport are highly developed. Therefore, the relative possibility for additional improvement from exogenous NO₃⁻ supplementation, even with a V̇O2max of 58.2 ml/kg/min, is inherently smaller compared to less-trained individuals. Conversely, less-trained individuals frequently have lower baseline NO bioavailability, less developed capillary density, less efficient microvascular control, and lower mitochondrial oxidative capacity. Thus, exogenous NO₃⁻, despite the same systemic increase in NO₃⁻, may produce a larger relative physiological change. Enhanced microvascular recruitment during effort could increase O₂ delivery and allow greater oxidative ATP production, thereby reducing reliance on anaerobic glycolysis and lowering lactate accumulation. This effect could also alter local O₂ extraction dynamics and greater re-saturation during recovery when perfusion is improved36,41. Although chronic BJ supplementation is often recommended to maximize ergogenic effects11,39,41, our study extends previous reports by indicating that acute consumption of BJ induces ergogenic effects on performance recovery. Importantly, this study is the first to show such effects on a judo-specific performance. While our study demonstrated statistically significant improvements in several physiological recovery markers following BJ supplementation, it is crucial to differentiate between statistical significance and practical or competitive relevance, particularly given the absence of a significant effect on TT. The small sample size and/or a fixed, short-duration nature of the SJFT may limit its sensitivity to detect subtle improvements in throw rate that do not directly translate into an increase in whole numbers within the given timeframe. However, the observed attenuation of physiological cost and improved recovery markers hold substantial practical significance for judo athletes. In competitive judo, athletes often engage in multiple high-intensity bouts within a single day or tournament. The ability to recover more rapidly and mitigate cumulative fatigue between these efforts is critical for maintaining performance quality, decision-making, and technique across successive matches. BJ’s capacity to reduce the metabolic burden of exercise and accelerate recovery could therefore enhance an athlete’s preparation for subsequent bouts, improve training adaptations over time, and potentially reduce the risk of fatigue-related errors or injuries. Thus, while not directly increasing the TT in an isolated test, the enhanced recovery profile observed with BJ may contribute significantly to a judoka’s overall competitive endurance and sustained performance in real-world, multi-bout scenarios. BJ represents a natural, accessible, and cost-effective recovery ergogenic aid for judokas at all levels, particularly for recreational or developing athletes who may benefit most from this substance and may not have access to more expensive supplementation strategies. Several limitations should be considered when interpreting the results. First, the study sample comprised primarily young adults, and results may not directly apply to adolescent or older judokas due to potential age-related differences in physiological responses. Second, although our sample size was calculated to detect small to moderate effects, the observed modest increase in TT, though not statistically significant, suggests the statistical power for detecting smaller effects related to this specific outcome might have been insufficient. To provide a more constructive perspective on statistical power for TT, a post-hoc power analysis was performed based on the observed mean differences and SDs for TT and an alpha level of 0.05. The statistical power for detecting the observed effect was approximately 7.8% for elite judokas (Cohen’s d = 0.08) and 20.9% for recreational judokas (Cohen’s d = 0.25). These low post-hoc power values strongly suggest that our study was indeed underpowered to detect statistically significant changes in TT, increasing the likelihood of a Type II error for this outcome. A larger sample size, therefore, is necessary to fully capture such smaller performance changes. Third, the heterogeneity of our study population, which included both male and female participants across two distinct training levels, warrants discussion. While this design allowed for insights into differential responsiveness based on training status, it introduces variability. To address potential confounding, we performed statistical analyses to test for main effect of sex and sex × intervention interaction effects for study outcomes, and no significant interactions were detected (p > 0.05). This suggests that the primary effects of BJ were consistent across sexes within our study cohort. However, we acknowledge that the relatively small sample sizes for each subgroup preclude definitive conclusions regarding subtle sex-specific responses. Therefore, while our findings suggest a generalized effect across sexes for the studied outcomes, the generalizability to specific sex-defined populations should be interpreted with caution. Future research with larger, sex-balanced cohorts is encouraged to explore potential nuanced sex-specific responses to BJ supplementation in judo. Fourth, our pre-test standardization protocol did not control for other acute factors known to influence performance, such as recent sexual activity42, or account for seasonal/environmental variations43, which could potentially modulate responses to supplementation or exercise. Regarding measurement, blood lactate was assessed only at 5 min post-exercise, a time point chosen based on our pilot data indicating peak lactate occurrence at this interval (12.3 ± 2.1, 14.2 ± 2.7, and 13.7 ± 2.6 mmol/L in 3, 5 and 8 min after SJFT, respectively). However, this single time point may not fully capture the complete lactate trajectory due to inter-individual variability in accumulation and clearance rates. While plasma NO3⁻ levels increased significantly following BJ supplementation, however, plasma NO₂⁻ concentrations were below the assay’s quantification limit, preventing direct measurement. Similarly, we did not obtain skeletal muscle biopsies or continuous autonomic measures (e.g., HR variability). Therefore, while the observed physiological changes (e.g., reduced HR₁, faster TSI re-saturation) are compelling, direct proof that enhanced NO availability mediated these effects via specific vascular or autonomic pathways requires future research incorporating more detailed tissue-level measurements and continuous monitoring. Conclusions Acute BJ supplementation (∼12.8 mmol NO₃⁻) primarily reduced the physiological cost and enhanced recovery-related markers during the special judo performance, particularly in less-trained athletes, without significantly increasing performance. These findings suggest that BJ improves recovery efficiency (recovery ergogenic) rather than direct task output (performance ergogenic) in the context of high-intensity explosive bouts like the SJFT, with training status modulating responsiveness. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Supplementary Material 4. Acknowledgements We are grateful to all the participants for their valuable time and contribution to this study. Author contributions Investigation, Conceptualization and Methodology: D.K., H.S., and I.G.; Data curation: I.G., B.F., E.K., and S.A.; Formal analysis: D.K., M.B., and H.S.; Writing—original draft: I.G., B.F., E.K., S.A., M.B., and I.L.; Writing—review and editing: D.K., H.S., and I.L.; Project administration: D.K. All authors have read and agreed to the final manuscript. Funding The authors received no specific funding for this study. Data availability All data sets are available from the corresponding author upon request. Competing interests The authors declare no potential conflicts of interest. Declaration of generative AI in scientific writing During the preparation of this work, the authors utilized ChatGPT to improve the manuscript. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Supplementary Material 4. Data Availability Statement All data sets are available from the corresponding author upon request.